Janssen seeks European marketing authorisation for subcutaneous (under the skin) daratumumab (Darzalex®)Access, Myeloma19 July 2019
HARMONY reaches milestone capturing data from 45,000 patients with blood cancersMPE, Myeloma25 June 2019
Takeda announces discontinuation of the phase 3 clinical trial TOURMALINE-AL1 in AL amyloidosisAccess, AL amyloidosis6 June 2019
ASCO 2019 – Lenalidomide reduces risk that smoldering myeloma will progress to myeloma in high risk patientsConferences, Myeloma31 May 2019
Lenalidomide and pomalidomide based triplet combination regimens for myeloma patients receives approval from the European CommissionAccess, Myeloma23 May 2019
Call to action for Central and Eastern European (CEE) members – join MPE CEE workgroup on accessAccess, MPE6 May 2019
